Format

Send to

Choose Destination
Med Decis Making. 2005 Jul-Aug;25(4):437-48.

Systematic review of economic evaluations of smoking cessation: standardizing the cost-effectiveness.

Author information

1
Department of Health Organisation, Policy and Economics, Maastricht University, Maastricht, The Netherlands. S.Ronckers@BEOZ.unimaas.nl

Abstract

OBJECTIVES:

This study was performed to render cost-effectiveness studies on smoking cessation therapies, utilized until now, more comparable and more useful for medical decision making.

METHODS:

The cost-effectiveness ratios reported by the studies were recalculated using a societal perspective and guidelines for economic evaluation.

RESULTS:

The costs of individual interventions generally increased as a result of the standardization procedure, whereas the effect size decreased. This resulted in increases in the cost-effectiveness ratios for individual studies ranging from 120% to 5600%.

CONCLUSIONS:

The variation between studies in the percentage increase in cost-effectiveness ratios is huge. This means that not following guidelines when calculating cost-effectiveness ratios can result in large errors. Despite the fact that the standardized cost-effectiveness ratios of smoking interventions were higher than the unstandardized cost-effectiveness ratios, interventions aimed at reducing the prevalence of smoking are cost-effective.

PMID:
16061896
DOI:
10.1177/0272989X05278431
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center